Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Highly sensitive biosafety model for stem-cell-derived grafts.

B Lawrenz1, H Schiller, E Willbold

  • 1CARDION AG, Erkrath, Germany.

Cytotherapy
|June 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting live birth following single euploid frozen-embryo transfer via β-hCG dynamics: iHOPE prognostic model with external validation.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Outcomes of GnRH agonist trigger in dydrogesterone-based PPOS versus GnRH antagonist cycles: a retrospective parallel cohort in freeze-all IVF treatment.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Challenges and limitations of anal cancer and precancer screening among people with HIV in a real-world setting.

Infection·2026
Same author

Assessing the risk of ectopic pregnancy following euploid frozen embryo transfer: a retrospective cohort study.

Journal of assisted reproduction and genetics·2025
Same author

Assessment of interindividual follicular size variation at ovulation in natural-cycle frozen embryo transfer.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
Same author

Undetected, natural conception pregnancies in luteal phase stimulations-case series and review of literature.

Human reproduction (Oxford, England)·2024
Same journal

CAR T cells: The next frontier.

Cytotherapy·2026
Same journal

Dialysis bioreactor enables high-density, serum-free expansion of dental pulp-derived mesenchymal stromal cells with enhanced secretome.

Cytotherapy·2026
Same journal

Beyond the synapses: should we anticipate neurotransmitter signaling when manufacturing CAR-T cells for brain tumors?

Cytotherapy·2026
Same journal

Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapy.

Cytotherapy·2026
Same journal

Manufacturing strategies for prolonged CAR-T cell persistence.

Cytotherapy·2026
Same journal

Overcoming five main challenges to targeting hematologic malignancies.

Cytotherapy·2026
See all related articles

A new animal model reliably detects tumorigenic stem cells, even as few as two cells, ensuring safer regenerative cell therapies. This biosafety model aids in developing non-tumorigenic cell populations for clinical use.

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Cancer Biology

Background:

  • Stem cell-derived therapies offer regenerative potential but carry tumorigenic risks.
  • Embryonic stem cells (ESCs) are promising for transplantation due to self-renewal and proliferation.
  • Mandatory biosafety testing is crucial to mitigate the safety concerns associated with ESCs' tumorigenic properties.

Purpose of the Study:

  • To establish a highly sensitive animal model for evaluating the proliferative and tumorigenic potential of stem cell grafts.
  • To ensure the biosafety of stem cell-derived transplants for clinical applications.

Main Methods:

  • BALB/c nude mice received grafts of non-neoplastic MRC-5 cells with varying numbers of mouse ESCs.
  • Cells were transplanted via kidney capsule injection or subcutaneous (s.c.) injection with Matrigel.

Related Experiment Videos

  • Immunocompetent mice were also used to assess the impact of immune response on tumor development.

    • Main Results:

    • The nude mouse model detected as few as 2 tumorigenic ESCs, forming teratomas.
    • Subcutaneous injection with Matrigel demonstrated the highest sensitivity, detecting 100% of 20 tumorigenic ESCs.
    • Tumor incidence was higher in immunodeficient nude mice than in immunocompetent mice, highlighting immune system influence.

    Conclusions:

    • A reliable animal model for routine biosafety assessment of stem cell-derived transplants has been developed.
    • This model facilitates the generation of homogenous, non-tumorigenic cell populations.
    • It aids in integrating standardized safety systems for clinical stem cell therapy.